Lawrence A. Tabak

Lawrence A. Tabak
Lawrence A. Tabak
Acting Director of the National Institutes of Health
	In office; December 20, 2021 – November 8, 2023
President	Joe Biden
Deputy	Tara A. Schwetz (acting)
Preceded by	Francis Collins
Succeeded by	Monica Bertagnolli
Principal Deputy Director of the National Institutes of Health
	Incumbent
	Assumed office ; August 2010
Preceded by	Raynard S. Kington
Succeeded by	Tara A. Schwetz (acting)
Director of the National Institute of Dental and Craniofacial Research
	In office; September 2000 – August 2010
Preceded by	Harold C. Slavkin
Succeeded by	A. Isabel Garcia (acting)
Director of the National Institute of Nursing Research
	Acting
	In office; October 2019 – December 2019
Preceded by	Ann K. Cashion (acting)
Succeeded by	Tara A. Schwetz (acting)
Personal details
Education	City College of New York (BS); Columbia University (DDS); University at Buffalo (PhD)
	Scientific career
Fields	Biochemistry; Dentistry
Thesis	Structural and functional studies of monkey salivary mucin (1981)

Lawrence A. Tabak (born 1951^[1]) is an American dentist and biomedical scientist serving as the principal deputy director of the National Institutes of Health. He served as acting director from 2021 to 2023. Previously he was the director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.

Education[edit]

Tabak is a native of Brooklyn, New York. He received his undergraduate degree from City College of New York, his D.D.S. from Columbia University College of Dental Medicine, and both a Ph.D. and certificate of proficiency in endodontics from the University at Buffalo.^[2] Tabak's 1981 dissertation was titled Structural and functional studies of monkey salivary mucin.^[3]

Career[edit]

Tabak was the senior associate dean for research and professor of dentistry and biochemistry and biophysics in the University of Rochester Medical Center. He was a National Institutes of Health MERIT Award recipient, Tabak's major research focus has been on the structure, biosynthesis and function of glycoproteins. He continues work in this area, maintaining an active research laboratory within the NIH intramural program in addition to his administrative duties.^[4]

Tabak served as the director of the National Institute of Dental and Craniofacial Research from 2000 to 2010. He served as acting NIH deputy director in 2009 and was the acting director of the Division of Program Coordination, Planning, and Strategic Initiatives.^[2] Tabak succeeded Raynard S. Kington as the NIH principal deputy director in August 2010.^[2] Tabak serves as the deputy ethics counselor of the NIH.^[4] In October 2019, Tabak succeeded Ann K. Cashion as the acting director of the National Institute of Nursing Research.^[5] He was succeeded by Schwetz in January 2020.^[6]

On December 20, 2021, Tabak succeeded Francis Collins as acting director of the NIH. Tara A. Schwetz will serve in Tabak's previous role as the acting principal deputy director of the NIH.^[7]

Awards and honors[edit]

Tabak is an elected member the National Academy of Medicine.^[4] He is a Fellow of the American Association for the Advancement of Science.^[2]

References[edit]

^ "Lawrence A. Tabak". c250.columbia.edu. Retrieved 2022-09-18.
^ Jump up to: ^a ^b ^c ^d "Lawrence A. Tabak named principal deputy director NIH". National Institutes of Health (NIH). 2015-08-26. Retrieved 2021-10-05. This article incorporates text from this source, which is in the public domain.
^ Tabak, Lawrence A. (1981). Structural and functional studies of monkey salivary mucin (Ph.D. thesis). State University of New York at Buffalo. OCLC 8395645. ProQuest 303190511.
^ Jump up to: ^a ^b ^c "Lawrence A. Tabak, D.D.S., Ph.D." National Institutes of Health (NIH). 2015-08-07. Retrieved 2021-10-05. This article incorporates text from this source, which is in the public domain.
^ "NINR Acting Director and Scientific Director Dr. Ann Cashion to Retire". www.ninr.nih.gov. August 20, 2019. Retrieved 2022-10-10.
^ "A Message from the NINR Acting Director, Dr. Lawrence A. Tabak | National Institute of Nursing Research". www.ninr.nih.gov. Retrieved 2022-10-13.
^ "Longtime No. 2 at NIH Tapped to Serve as Acting Director (1)". Bloomberg Law. December 9, 2021. Retrieved 2021-12-23.

This article incorporates public domain material from websites or documents of the National Institutes of Health.

External links[edit]

Appearances on C-SPAN

Government offices
Preceded by Francis Collins	Director of the National Institutes of Health Acting 2021–2023	Succeeded by Monica Bertagnolli

[1] "Lawrence A. Tabak". c250.columbia.edu. Retrieved 2022-09-18.

[:1-2] Jump up to: ^a ^b ^c ^d "Lawrence A. Tabak named principal deputy director NIH". National Institutes of Health (NIH). 2015-08-26. Retrieved 2021-10-05. This article incorporates text from this source, which is in the public domain.

[3] Tabak, Lawrence A. (1981). Structural and functional studies of monkey salivary mucin (Ph.D. thesis). State University of New York at Buffalo. OCLC 8395645. ProQuest 303190511.

[:0-4] Jump up to: ^a ^b ^c "Lawrence A. Tabak, D.D.S., Ph.D." National Institutes of Health (NIH). 2015-08-07. Retrieved 2021-10-05. This article incorporates text from this source, which is in the public domain.

[5] "NINR Acting Director and Scientific Director Dr. Ann Cashion to Retire". www.ninr.nih.gov. August 20, 2019. Retrieved 2022-10-10.

[6] "A Message from the NINR Acting Director, Dr. Lawrence A. Tabak | National Institute of Nursing Research". www.ninr.nih.gov. Retrieved 2022-10-13.

[7] "Longtime No. 2 at NIH Tapped to Serve as Acting Director (1)". Bloomberg Law. December 9, 2021. Retrieved 2021-12-23.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Authority control databases
International	ISNI VIAF
National	Norway Israel Belgium United States Netherlands
Academics	Google Scholar ORCID Scopus
Other	IdRef